Biotech stocks had a bad week after turmoil at the FDA, continuing a long period of underperformance after the pandemic. Many ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...

Here are two biotech stocks that Wall Street is very bullish ... and commercializing new treatments for gastrointestinal (GI) diseases. In July 2024, the U.S. Food and Drug Administration (FDA ...

The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through its development stages -- and the stock could continue to gain after that company moves ...

This fund holds a portfolio of 75-125 biotechnology stocks, balanced between established large-cap names and smaller companies with more growth potential but also more risk. The managers aim to ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN ...

These names in the biotech sector are seeing a substantial ... The company’s programs address significant unmet needs in GI health and include: latiglutenase, potentially first-in-class ...

Pipeline and key clinical candidates for these companies: Arvinas is a clinical-stage biotechnology company that says it is “dedicated to improving the lives of patients suffering from ...